Ole S. Søgaard

Aarhus University - Department of Infectious Diseases

Aarhus

Denmark

SCHOLARLY PAPERS

4

DOWNLOADS

558

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Levels of SARS-CoV-2 Antibodies Among Fully-Vaccinated Individuals With Delta or Omicron Variant Breakthrough Infections: A Prospective Cohort Study

Number of pages: 18 Posted: 25 Mar 2022
Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, University of Copenhagen - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Cardiology, University of Copenhagen - Department of Cardiology, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Clinical Medicine, Aarhus University - Department of Clinical Immunology, University of Copenhagen - Department of Public Health, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP and Aarhus University - Department of Infectious Diseases
Downloads 380 (160,531)
Citation 1

Abstract:

Loading...

SARS-CoV-2, COVID-19, vaccination, antibody, serology, breakthrough infection, Omicron, Delta

2.

SARS-CoV-2 Vaccine-Induced Antibodies Protect Against Omicron Breakthrough Infection

Number of pages: 20 Posted: 24 Feb 2023
Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Infectious Diseases, University of Copenhagen - Department of Cardiology, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Public Health, Aarhus University - Department of Clinical Immunology, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 88 (587,500)

Abstract:

Loading...

SARS-CoV-2, Omicron, COVID-19, Breakthrough Infection, Antibodies, Vaccination, Seroconversion, Case-Control

3.

The Impact of Analytical Treatment Interruptions and Trial Interventions on Time to Viral Re-Suppression in People Living with HIV Restarting ART in Cure-Related Clinical Studies: A Systematic Review and Meta-Analysis

Number of pages: 33 Posted: 29 Sep 2023
Guy's and St Thomas' NHS Foundation Trust - Harrison Wing, Imperial College London, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, Ghent University, University of Pennsylvania, University of Pennsylvania - Department of Medicine, Aarhus University, Aarhus University - Department of Infectious Diseases, University of Antwerp - Institute of Tropical Medicine (ITM), Thai Red Cross AIDS Research Centre, Bangkok - SEARCH, Thai Red Cross AIDS Research Centre, Bangkok - SEARCH, IrsiCaixa AIDS Research Institute-HIVACAT, Rockefeller University - Laboratory of Molecular Immunology and Imperial College London - Section of Virology
Downloads 57 (738,130)

Abstract:

Loading...

HIV, Antiretroviral Therapy, Analytical Treatment Interruption, Treatment Interruption, ATI, Viral Suppression

4.

Redirector of Vaccine-Induced Effector Responses (RoVER) for Specific Killing of Cellular Targets

Number of pages: 27 Posted: 28 Sep 2022
Aarhus University - Department of Clinical Medicine, Aarhus University - Department of Clinical Medicine, Aarhus University - Department of Clinical Medicine, Aarhus University - Department of Infectious Diseases, affiliation not provided to SSRN, affiliation not provided to SSRN, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 33 (917,911)

Abstract:

Loading...

Immunotherapy, Vaccine, Cytotoxic T lymphocytes, Redirection, Cancer, HIV-1 infection